Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2026)

Vir Biotechnology has reported Amortizatization of Intangibles for 9 years, with the latest figure at -$394000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 90.36% year-over-year to -$394000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.8 million (up 37.51% YoY) and the FY2025 annual result came in at -$9.5 million, down 75.54% from the prior year.
• Amortizatization of Intangibles climbed to -$394000.0 in Q1 2026 per VIR's latest filing, from -$1.5 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $9.4 million in Q1 2023 and troughed at -$4.1 million in Q1 2025.
• A 5-year average of $140235.3 and a median of -$1.1 million in 2022 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles soared 1340.33% in 2022, then tumbled 1618.07% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $7.6 million in 2022, then sank by 117.71% to -$1.4 million in 2023, then tumbled by 60.47% to -$2.2 million in 2024, then gained by 28.55% to -$1.5 million in 2025, then surged by 74.56% to -$394000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$394000.0, -$1.5 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.